CRCA vs. ADBG
CRCA (ProShares Ultra CRCL) and ADBG (Leverage Shares 2X Long ADBE Daily ETF) are both Leveraged Equities funds. Both are actively managed. At a 0.17 correlation, their price movements are largely independent. CRCA charges 0.95%/yr vs 0.75%/yr for ADBG.
Performance
CRCA vs. ADBG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -68.22% return, which is significantly lower than ADBG's -63.31% return.
CRCA
- 1D
- -9.58%
- 1M
- -40.68%
- 6M
- -70.42%
- YTD
- -68.22%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ADBG
- 1D
- 6.23%
- 1M
- 25.00%
- 6M
- -57.82%
- YTD
- -63.31%
- 1Y
- -69.16%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CRCA vs. ADBG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -68.22% | -84.67% |
ADBG Leverage Shares 2X Long ADBE Daily ETF | -63.31% | -5.57% |
Correlation
The correlation between CRCA and ADBG is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025 | 0.17 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. ADBG — Risk / Return Rank
CRCA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
ADBG
CRCA vs. ADBG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Leverage Shares 2X Long ADBE Daily ETF (ADBG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRCA | ADBG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 0.80 | — |
| Calmar ratioReturn relative to maximum drawdown | — | -0.88 | — |
| Martin ratioReturn relative to average drawdown | — | -1.51 | — |
Loading charts...
Drawdowns
CRCA vs. ADBG - Drawdown Comparison
The maximum CRCA drawdown since its inception was -95.18%, which is greater than ADBG's maximum drawdown of -84.14%. Use the drawdown chart below to compare losses from any high point for CRCA and ADBG.
Loading charts...
Drawdown Indicators
| CRCA | ADBG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.18% | -84.14% | -11.04% |
Max Drawdown (1Y)Largest decline over 1 year | — | -78.97% | — |
Current DrawdownCurrent decline from peak | -95.13% | -77.72% | -17.41% |
Average DrawdownAverage peak-to-trough decline | -72.99% | -44.55% | -28.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 45.66% | — |
Volatility
CRCA vs. ADBG - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | ADBG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 28.99% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 61.05% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 195.27% | 70.76% | +124.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 195.27% | 69.07% | +126.20% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 195.27% | 69.07% | +126.20% |
CRCA vs. ADBG - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is higher than ADBG's 0.75% expense ratio.
Dividends
CRCA vs. ADBG - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 6.93%, while ADBG has not paid dividends to shareholders.
| Position | TTM | 2025 |
|---|---|---|
ADBG Leverage Shares 2X Long ADBE Daily ETF | 0.00% | 0.00% |
CRCA ProShares Ultra CRCL | 6.93% | 1.06% |
Frequently Asked Questions
CRCA and ADBG have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, ADBG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.
ADBG is cheaper with a 0.75% expense ratio, compared with 0.95% for CRCA.
CRCA has the higher dividend yield at 6.93%, compared with 0.00% for ADBG.
They also come from different issuers: ProShares and Leverage Shares. Their fees differ too: 0.95% for CRCA and 0.75% for ADBG.
Find the right allocation for CRCA and ADBG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer